Novel Translational Pharmacology Approaches On Dose Reduction And Alternative Scheduling For The Combination Of Jak Inhibitor, Ruxolitinib, Pim Inhibitor, Lgh447, And Cdk4/6 Inhibitor, Lee011 In A Preclinical Model Of Myeloproliferative Neoplasia
CANCER RESEARCH(2015)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined